Reumatoloxía
Servicio
Eugenio de
Miguel Mendieta
Publicacións nas que colabora con Eugenio de Miguel Mendieta (36)
2024
-
18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry
Journal of Clinical Medicine, Vol. 13, Núm. 20
-
Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis
European Journal of Internal Medicine, Vol. 129, pp. 78-86
-
Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature
Arthritis Research and Therapy, Vol. 26, Núm. 1
-
Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register
RMD open, Vol. 10, Núm. 1
-
Natural language processing to identify and characterize spondyloarthritis in clinical practice
RMD Open, Vol. 10, Núm. 2
-
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study
The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383
2023
-
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients
Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836
2022
-
Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register
RMD Open, Vol. 8, Núm. 2
-
Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists
Rheumatology International, Vol. 42, Núm. 3, pp. 441-448
-
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
Therapeutic Advances in Musculoskeletal Disease, Vol. 14
2021
-
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
Therapeutic Advances in Musculoskeletal Disease, Vol. 13
2020
-
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119
2019
-
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135
2017
-
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis
American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74
-
A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis
Rheumatology International, Vol. 37, Núm. 8, pp. 1347-1356
-
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy
Scientific Reports, Vol. 7
-
Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort
Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942
-
Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis
Arthritis Care and Research, Vol. 69, Núm. 1, pp. 150-155
2016
-
Differences between familial and sporadic early spondyloarthritis: Results from the ESPERANZA cohort
Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 575-580
2014
-
Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis
Clinical and Experimental Rheumatology, Vol. 32, Núm. SUPPL.82